Prevalence of pigmentary disorders diagnosed by dermatologists and their impact: results of the first large international survey

B. Dreno, S. Puig, L. Wei, A. Morita, C.L. Goh, H.Y. Kang, F. Ly, S. Schalka, J. Ocampo Candiani, A.L. Demessant, C. Le Floc’h, D. Kerob, A. Alexis, J. Krutmann, H.W. Lim, T. Passeron

  • 10min
  • Oct. 2023
  • Supported by
  • La Roche-Posay
Poster

INTRODUCTION AND OBJECTIVES


Pigmentary disorders (PD) are frequent dermatological conditions, but little is known on their real-world prevalence and impact. This first worldwide survey evaluates the self-reported prevalence of PD such as Melasma, Post-inflammatory Hyperpigmentation (PIH), Solar Lentigo, Vitiligo, Peri-Orbital Hyperpigmentation (POH) and Axillary Hyperpigmentation (AH), their impact on quality of life (QOL) and stigmatization. We present here the results among people who had a diagnosis for their PD by a dermatologist (PDD) versus the ones who were diagnosed another way (self-diagnosed or by another HCP) (nPDD).